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Edited by Judit Ova´diAbstract Parathyroid hormone (PTH) binds to its receptor
(PTH 1 receptor, PTH1R) and activates multiple pathways.
The PTH1R, a class b GPCR, contains consensus calmodulin-
binding motifs. The PTH1R cytoplasmic tail interacts with cal-
modulin in a calcium-dependent manner via the basic 1-5-8-14
motif. Calcium-dependent calmodulin interactions with the cyto-
plasmic tails of receptors for PTH 2, vasoactive intestinal
peptide, pituitary adenylate cyclase activating peptide, cortico-
tropin releasing hormone, calcitonin, and the glucagon-like pep-
tides 1 and 2 are demonstrated. The cytoplasmic tails of the
secretin receptor and the growth hormone releasing hormone
receptor either interact poorly or not at all with calmodulin,
respectively. Fluphenazine, a calmodulin antagonist, enhances
PTH-mediated accumulation of total inositol phosphates, sug-
gesting that calmodulin regulates signaling via phospholipase C.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The parathyroid hormone 1 receptor (PTH1R) is a class b
G-protein coupled receptor (GPCR) that is bound and acti-
vated by two prominent ligands, parathyroid hormone
(PTH), an endocrine factor involved in mineral ion homeosta-
sis, and PTH-related protein (PTHrP), an autocrine/paracrine
factor involved in development [1]. The PTH1R couples to Gs,
Gq/11 and Gi/o and signals via adenylyl cyclase (AC) and
phospholipase C (PLC) [2,3]. Cell-speciﬁc responses elicited
by PTH or PTHrP are undoubtedly dependent upon the com-Abbreviations: PTH, parathyroid hormone; PTHrP, parathyroid
hormone related protein; PTH1R, parathyroid hormone 1 receptor;
GPCR, G-protein coupled receptor; CaM, calmodulin; PLC, phos-
pholipase C; AC, adenylyl cyclase; PTH2R, PTH 2 receptor; PACPR,
pituitary adenylate cyclase activating peptide receptor; VIP1R, vaso-
active intestinal peptide 1 receptor; CRF1R, corticotropin releasing
hormone 1 receptor; CALTR, calcitonin receptor; GLP1R and GL-
P2R, glucagon-like peptide receptors 1 and 2; SECRR, secretin rece-
ptor; GHRHR, growth hormone releasing hormone receptor; OK,
opossum kidney cells
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demonstrates that non-G protein, cytosolic factors bind to
and regulate the activity of the PTH1R. The sodium-hydrogen
exchanger regulatory factors (NHERFs) 1 and 2 bind to the
carboxyl terminus of the PTH1R and enhance signaling via
PLC [2,3].
Calmodulin (CaM) is a conserved, ubiquitous, calcium sens-
ing protein that binds and regulates many intracellular pro-
teins, including cytoskeletal elements, ion channels, kinases,
phosphatases and enzymes associated with GPCR signaling,
such as AC, phosphodiesterase and PLC [4]. Two generalized
CaM-binding motifs exist. The Ca2+-independent CaM-bind-
ing site based on myosin interactions contains the consensus
sequence shown in Table 1 and is referred to as the IQ-motif
named for the ﬁrst two conserved amino acid residues [5].
The Ca2+-dependent CaM-binding motif is more divergent
and is primarily based on positions of conserved hydrophobic
residues ﬂanked by basic residues [5]. These motifs are referred
to as either the basic 1-5-8-14 (Table 1) or basic 1-5-10. Here,
we show that the PTH1R and a sub-set of class b GPCRs bind
to CaM in a Ca2+-dependent manner via determinants in the
cytoplasmic, carboxy-terminal tails.2. Materials and methods
2.1. Reagents
The pGex vector and glutathione–Sepharose were from Pharmacia/
Amersham. The bacterial expression vector p30, S-protein-HRP and
rapid S-tag assay kit were from Novagen. The Ni2+-chelate column
(Ni–NTA) was purchased from Qiagen. ECL Western lightning re-
agent was from Perkin–Elmer. Secondary-antibodies conjugated to
Alexa Fluor 546 were obtained from Molecular Probes. Pfu polymer-
ase was purchased from Stratagene and restriction enzymes were from
Promega. Flag-speciﬁc monoclonal antibodies and general chemicals
were from Sigma.2.2. GST pull-down assay
The full-length cytoplasmic, carboxy-terminal tail (C-tail) of the
PTH1R (amino acids 463–591) was cloned into the p30 vector generat-
ing an N-terminal his6- and S-tag. PTH1R C-tail amino-terminal dele-
tions of 5 (amino acids 468–591), 10 (473–591), 15 (478–591) and 20
(483–591) residues and the various point mutations were generated
using PCR-directed mutagenesis. Full-length carboxy-terminal tails
of the PTH 2 receptor (PTH2R, amino acids 417–550), vasoactive
intestinal peptide receptor (VIP1R, 392–457), pituitary adenylate cy-
clase activating peptide receptor (PACPR, 461–525), corticotropin
releasing hormone 1 receptor (CRF1R, 367–415), calcitonin receptor
(CALTR, 396–482), the glucagon-like peptide receptors 1 (GLP1R,
406–463) and 2 (GLP2R, 440–553), secretin receptor (SECRR,ation of European Biochemical Societies.
Fig. 1. CaM binds to the carboxy-terminal tail of the PTH1R in a
Ca2+-dependent manner. GST alone or GST fused to CaM were
interacted with the PTH1R C-tail (100 nM), as described in Section 2,
in the presence of either 1 mM CaCl2 or 1 mM EGTA, as indicated.
Interactors were eluted with glutathione and blotted with S-protein-
HRP.
Table 1
CaM-binding motifs in the PTH1R
Type Motif
IQ (IVL)QxxxRxxxx(RK)xx(FILVWY)
PTH1R 463a – NGEVQAEIRKSWSRWTLALDFKRKA – 487a
1-5-8-14 (FILVW)xxx(FAILVW)xx(FAILVW)xxxxx(FILVW)
PTH1R 463a – NGEVQAEIRKSWSRWTLALDFKRKA – 487a
aAmino acid position in rat PTH1R.
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(GHRHR, 376–419) were cloned into the p30 vector using PCR.
Full-length CaM was cloned into the pGex vector generating a fusion
with glutathione S-transferase (GST-CaM). All plasmid constructs
were veriﬁed by sequencing using an ABI Prism sequencer.
The p30-C-tails and the GST-CaM were expressed in BL21-DE3-
pLysS Esherichia coli strain. The C-tails were partially puriﬁed using
immobilized metal aﬃnity chromatography using Ni–NTA from Qia-
gen, following the manufacturers protocols. Protein concentrations
were determined using the S-tag rapid assay kit (Novagen). GST alone
or GST-CaM were coupled to glutathione–Sepharose and mixed with
the above C-tail preparations (100 nM) in a buﬀer containing 25 mM
HEPES, pH 7.4, 20% glycerol, 150 mM NaCl, 1 mM dithiothreitol, a
protease inhibitor cocktail (Sigma) and 10 mg/ml of a crude bacterial
lysate for 4 h at 4 C. The presence or absence of either 1 mM EGTA
or 1 mM CaCl2 is indicated in the ﬁgures. The GST-CaM/C-tail com-
plex was eluted with 5 mM glutathione and analyzed by SDS–PAGE
and blotting using S-protein-HRP and enhanced chemiluminescence.2.3. Immunohistochemistry
CaM was cloned into a pcDNA3.1 vector (Invitrogen) that places an
N-terminal ﬂag epitope on the full-length cDNA (ﬂag-CaM). The yel-
low ﬂuorescent protein was cloned in-frame with the PTH1R (PTH1R-
YFP), as previously described [5]. Opossum kidney (OK) cells cultured
in DMEM/F12 plus 10% fetal bovine were transiently transfected with
ﬂag-CaM and PTH1R-YFP using FuGene 6 (Roche). The cells were
ﬁxed with 2% paraformaldehyde in phosphate-buﬀered saline (PBS),
permeabilized and blocked with 5% non-fat milk in PBS containing
0.1% Triton X-100, and probed with ﬂag-speciﬁc antibodies and sec-
ondary antibodies conjugated with Alexa Fluor 546. Images were ac-
quired using a Radiance 2000 confocal microscope and the
associated software (BioRad).2.4. Determination of inositol phosphates
HEK293 cells cultured in DMEM plus 10% fetal bovine serum were
plated in 12-well plates and transiently transfected with the PTH1R
using FuGene 6. Analysis of total inositol phosphates was as previ-
ously described [6].3. Results and discussion
Rhoads and Friedberg [5] reported that the PTH1R contains
a conserved IQ CaM-binding site (Table 1). The focus of this
report was to survey potential CaM-binding partners and thus
direct interactions between the PTH1R and CaM were not
investigated. Using the GST pull-down assay, GST-CaM dis-
plays a robust interaction with carboxy-terminal tail (C-tail)
of the PTH1R (Fig. 1). The IQ-binding motif found in the
PTH1R generally mediates Ca2+-independent interactions with
CaM. Unexpectedly, the PTH1R C-tail binds to CaM in a
Ca2+-dependent manner (Fig. 1).
Deleting amino acids from the N-terminus of the C-tail by
increments of ﬁve demonstrates that CaM binds to a region
located between amino acids 473 and 478 of the PTH1R
(Fig. 2). The consensus IQ motif in the PTH1R betweenamino acids 466 and 479 overlaps the CaM-binding region
demonstrated in Fig. 2. However, deleting 5 amino acids
from the N-terminus, which has no eﬀect on CaM binding,
removes the IQ portion of this motif. This ﬁnding suggests
that despite the overlap CaM does not bind to the PTH1R
C-tail via the IQ motif, which is also consistent with the
Ca2+-dependence for this interaction. The deletion analysis
demonstrates that the SWSRW sequence (amino acids 473–
477) is required for the CaM interaction. Individual alanine
substitutions for each residue of the SWSRW sequence on
the C-tail, however, did not inhibit interactions with CaM
(Fig. 2).
The inability of the alanine mutagenesis scan through the
CaM-binding domain to block interactions with the C-tail sug-
gests that alanine substitutions are tolerated. Notably, the
CaM interaction domain on the PTH1R C-tail nearly matches
the basic 1-5-8-14 binding motif (Table 1). The tryptophan res-
idues at amino acids 474 and 477 of the PTH1R correspond to
positions 5 and 8 in the basic 1-5-8-14 motif (Table 1). Impor-
tantly, alanines in positions 5 and 8 are acceptable residues for
the consensus-binding motif, which could explain why alanine
substitutions in these positions did not block CaM binding
(Fig. 2). Furthermore, the R476A mutation, which targets
the 4th position of the IQ motif, has no eﬀect on CaM binding
(Fig. 2). These ﬁndings, combined with the fact that this inter-
action is Ca2+-dependent, strongly suggest that CaM binds to
the PTH1R C-tail via the basic 1-5-8-14 motif. Sequence align-
ments of the class b GPCRs reveals that the CaM-binding re-
gion is semi-conserved (Table 2).
The C-tails of the class b receptors shown in Table 2 were
expressed in bacteria and interactions with GST-CaM as-
sessed. As shown in Fig. 3, CaM displays robust, Ca2+-
dependent interactions with the C-tails of the PTH2R,
PACPR, VIP1R, CRF1R, CALTR, and GLP1R and GLP2R.
The C-tail of the SECRR interacts poorly with CaM, while the
C-tail of the GHRHR does not interact at all (Fig. 3). The C-
tails of PACPR, VIP1R and CRF1R are expressed and puri-
ﬁed as fragments, which is more than likely due to conﬂicts
in mammalian codon usage in bacteria. However, all of these
fragments interact with GST-CaM in a Ca2+-dependent man-
ner, which also conﬁrms that the interaction domains are on
N-terminal portions of these C-tails.
Fig. 2. CaM interacts with N-terminal portions of the PTH1R C-tail.
The PTH1R C-tail (full), N-terminal amino acid deletions of the C-tail
of 5 (ND5), 10 (ND10), 15 (ND15) and 20 (ND20) and the following
alanine substitutions of the C-tail, S473A, W474A, S475A, R476A and
W477A (indicated by italics), were interacted with GST-CaM in the
presence of 1 mM CaCl2. Interactors were eluted and blotted with S-
protein-HRP.
Table 2
Sequence alignment of class b GPCRs
Receptora Sequenceb
PTH1R VQAEIRKSWSRWTLALDFKRKA
PTH2R VQAEVKKMWSRWNLSVDWKRTP
PACPR VQAEIKRKWRSWKVNRYFAVKF
VIP1R VQAELRRKWRRWHLQGVLGWNP
CRF1R VRSAIRKRWRRWQDKHSIRARV
CALTR VQGALKRQWNQYQAQRWAGRRS
GLP1R VQMEFRKSWERWRLERLNIQRD
GLP2R VKAELRKYWVRFLLARHSGCRA
SECRR VQLEVQKKWRQWHLQEFPLRPV
GHRHR VRTEISRKWHGHDPELLPAWRT
aPTH 2 receptor (PTH2R), pituitary adenylate cyclase activating
peptide receptor (PACPR), vasoactive intestinal peptide 1 receptor
(VIP1R), corticotropin releasing hormone 1 receptor (CRF1R), cal-
citonin receptor (CALTR), glucagon-like peptide receptors 1 (GLP1R)
and 2 (GLP2R), secretin receptor (SECRR) and growth hormone
releasing hormone receptor (GHRHR).
bAmino acids 466–487 of rat PTH1R.
Fig. 3. A sub-set of class b GPCRs interacts with CaM. GST alone (G;
1st lane of each panel) or GST-CaM (CaM; 2nd and 3rd lanes of each
panel) were interacted with the C-tails (100 nM) of the class b GPCRs
shown in Table 2 in either the presence of 1 mM CaCl2 (1st and 2nd
lanes of each panel) or 1 mM EGTA (3rd lane of each panel).
Interactors were eluted and blotted with S-protein-HRP.
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that displayed weak interactions with CaM (i.e., SECRR and
GHRHR) should highlight critical binding determinants for
this interaction. First, the SECRR has a glutamine at amino
acid 471 relative to the PTH1R sequence instead of an argi-
nine, which is conserved in the IQ-binding motif (Table 1). Sec-
ond, the GHRHR has a histidine substitution for the
conserved tryptophan at amino acid 477. Both SECRR and
GHRHR contain a proline instead of a phenylalanine at ami-
no acid 483 of the PTH1R. Using the SECRR and GHRHR as
guides, a series of point mutations were incorporated into the
PTH1R C-tail and interactions with CaM assessed.
An alanine substitution for the conserved glutamine at ami-
no acid 467 (Q467A) and glutamic acid (R471E) or glutamine
(R471Q) substitutions for arginine at position 471 do not aﬀect
CaM interactions (Fig. 4). These mutations target conserved
positions of the IQ motif (Table 1). Thus, CaM binding to
these mutants provides more evidence that these interactionsare not mediated by the IQ motif. Incorporating histidine for
the tryptophan at position 477 or a proline substitution for
the phenylalanine at 483 of the PTH1R also does not block
CaM interactions. These ﬁndings were unexpected because
these mutations, which are based on the GHRHR sequence
(Table 2), are key residues in the 8 and 14 positions of the basic
1-5-8-14 motif (Table 1).
Double point mutations incorporating alanines for the two
conserved tryptophan residues at positions 474 and 477
(CTWW) markedly inhibit CaM binding (Fig. 4). The double
point mutation, R471Q/F483P (CTQP) based on the SECRR
sequence, did not aﬀect CaM binding (Fig. 4). Conversely, fol-
lowing the GHRHR sequence, the double mutation, W477H/
F483P (CTHP), completely blocks CaM interactions with the
PTH1R C-tail (Fig. 4). Combined, these ﬁndings reveal that
the 5, 8 and 14 positions of the basic 1-5-8-14 motif are critical
determinants for the CaM/PTH1R interaction. Furthermore,
these data also demonstrate that the CaM/PTH1R interaction
occurs through multiple contacts considering that double point
mutations are required to eﬀectively block this association.
The PTH1R localizes to actin-rich, apical patches of opos-
sum kidney cells, complexes that are assembled in part by
the sodium-hydrogen regulatory factor 1 (NHERF-1) [3].
Opossum kidney cells were transiently transfected with the
PTH1R tagged with the yellow ﬂuorescent protein (PTH1R-
YFP) and CaM tagged with the ﬂag epitope. Confocal micro-
scopic analysis reveals that the PTH1R and CaM co-localize in
the apical patches of opossum kidney cells (Fig. 5). Interest-
ingly, CaM localized to these apical structures in only 20%
of the transfected cells, suggesting a dynamic interaction be-
tween the PTH1R and CaM in these cellular compartments.
The eﬀect of ﬂuphenazine, a CaM antagonist, on PTH signal-
ing via the PLC pathway was investigated. Fluphenazine in-
creases PTH elicited increases of total inositol phosphates
(Fig. 6), suggesting that CaM binding to the C-tail blocks
PTH signaling via PLC. Fluphenazine had no apparent eﬀect
on PTH1R signaling through AC (data not shown).
Several lines of evidence suggest that CaM plays a role in
PTH1R signaling. In perfused proximal convoluted tubules,
Fig. 5. CaM co-localizes with the PTH1R in apical membranes of OK
cells. OK cells were co-transfected with ﬂag-CaM (red) and PTH1R-
YFP (green), and stained with ﬂag antibodies and secondary antibod-
ies conjugated with Alexa Fluor 546. Representative confocal images
of the apical domain are shown.
Fig. 4. Mutational analysis of the CaM/PTH1R interaction. The wild
type PTH1R C-tail (full) and the C-tail containing the following point
mutations, Q467A, R471E, R471Q, W477H, F483P, W474A/W477A
(CTWW), R471Q/F483P (CTQP) and W477H/F483P (CTHP), as
indicated by italics, were interacted with GST-CaM in the presence of
CaCl2. Interactors were eluted and blotted with S-protein-HRP.
Fig. 6. Fluphenazine enhances PTH1R signaling via PLC. HEK293
cells transiently transfected with the PTH1R were treated with either
vehicle (DMSO) or the indicated concentrations of ﬂuphenazine for 15
min. Cells were then treated with PTH(1-34) at 100 nM and
accumulation of total inositol phosphates determined. Data are
representatives of three independent experiments (n = 6 ± S.E.M.).
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were abolished by the CaM antagonists, triﬂuoperazine and
W-7 [7]. CaM antagonists also inhibited PTH-induced rarefac-
tion of microvilli in primary cultures of proximal convoluted
tubule cells [8]. Furthermore, inhibition of CaM-kinase IImarkedly inhibits PTH-induced interstitial collagenase
(MMP13) mRNA expression in osteoblastic cells [9]. Lastly,
CaM antagonists inhibited PTHrP-mediated production of ni-
tric oxide from endothelial cell primary cultures [10].
CaM regulates GPCR activity via direct interactions. CaM
interacts with the l-opioid receptor via determinants in the
third intracellular loop and inhibits high-aﬃnity agonist bind-
ing to the receptor by displacing G proteins [11]. CaM also
binds to the V2 vasopressin receptor via determinants in the
cytoplasmic tail, an interaction that is required for arginine
vasopressin-induced elevations of intracellular calcium [12].
Speciﬁc isoforms of the group III metabotrophic glutamate
receptors interact with CaM via amino-terminal portions of
the cytoplasmic tails, an interaction that displaces Gbc
[13,14]. These ﬁndings reveal that sequence diversity among
the GPCR super-family, even within the same sub-set, pro-
vides receptor-speciﬁc regulatory elements, such as the CaM-
binding motifs, which reﬂect the function and regulation of a
given receptor. For the class b GPCRs, the absence of CaM
binding for the secretin and growth hormone releasing hor-
mone receptors suggests that regulation via CaM binding is
either not required for normal function or that CaM binding
would be deleterious to the normal action of these receptors.
Herein, we describe an interaction domain on the PTH1R
cytoplasmic tail that binds to CaM via the basic 1-5-8-14 mo-
tif. Notably, this domain is reasonably well conserved among
the class b GPCRs, and thus likely represents a common reg-
ulatory motif that is responsive to CaM and ﬂuctuations of
intracellular Ca2+.
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